In this context, it was reported that adiponectin could play a protective role in the pathogenesis of MASLD, reducing the inflammation by the inhibition of hepatic stellate cells and by upregulating the expression of eNOS [172,179,180,181]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.